RAVULIZUMAB
UNII C3VX249T6L

Substance Identification & Data

This profile provides standardized clinical and technical data for Ravulizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C3VX249T6L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1803171-55-2 and the RxNorm Concept ID (RxCUI) 2107301. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C3VX249T6L

CAS Registry Number

1803171-55-2

RxNorm Concept ID

2107301

Detailed Substance Profile

Preferred Name

RAVULIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

C3VX249T6L

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C124657

National Cancer Institute reference terminology for clinical and research data.

INN ID

10659

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-132

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ravulizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RAVULIZUMAB

RAVULIZUMAB-CWVZ

Common Names & Synonyms

IMMUNOGLOBULIN G2/G4, ANTI-(HUMAN COMPLEMENT C5) (HUMAN-MUS MUSCULUS ALXN1210 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS ALXN1210 .KAPPA.-CHAIN, DIMER

RAVULIZUMAB [INN]

RAVULIZUMAB [JAN]

RAVULIZUMAB [MI]

RAVULIZUMAB [USAN]

RAVULIZUMAB [WHO-DD]

RAVULIZUMAB CWVZ [WHO-DD]

RAVULIZUMAB-CWVZ [PURPLE BOOK CDER]